Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Low-Dose RADiotherapy in the Management of Immune Checkpoint- Inhibitor-ArThropathy as an Immune-Related Adverse Event (RADIATE)

NCT07478679 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT07478679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07478679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Low-Dose RADiotherapy in the Management of Immune Checkpoint- Inhibitor-ArThropathy as an Immune-Related Adverse Event (RADIATE)
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 26, 2026
Completion date
September 17, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, arthropathy